Human parvovirus B19 infection in pregnancy: should screening be offered to the low-risk population?
Human parvovirus B19 infection during pregnancy can result in fetal hydrops and death. Intra-uterine transfusion in hydropic fetuses affected by the virus can reduce perinatal deaths. Up to 33% of women with this infection are asymptomatic. In view of the significant adverse outcomes, the role of routine screening among low-risk pregnant women is discussed.
Wong
Shell Fean
SF
Department of Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, Queensland, Australia.
Chan
Fung Yee
FY
Cincotta
Robert B
RB
Tilse
Martin
M
Fean
Wong Shell
WS
Yee
Chan Fung
CF
D001315:Australia; D005260:Female; D006801:Humans; D008403:Mass Screening; D010322:Parvoviridae Infections / Q000175:diagnosis*; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D011295:Prenatal Care; D011296:Prenatal Diagnosis